CAS 1346527-98-7

Formule : C23H20N6O

InChI : InChI=1S/C23H20N6O/c1-30-19-13-7-10-16-20(19)27-23(28-21(16)25-14-15-8-3-2-4-9-15)29-18-12-6-5-11-17(18)26-22(29)24/h2-13H,14H2,1H3,(H2,24,26)(H,25,27,28)

Code InChI : NHAMBLRUUJAFOY-UHFFFAOYSA-N

SMILES : COC1=CC=CC2=C1N=C(N=C2NCC3=CC=CC=C3)N4C5=CC=CC=C5N=C4N

CID-49830258

CAS : 1346527-98-7

Formule : C₂₃H₂₀N₆O

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 396.4445

Ref: IN-DA009CN8

ML240

CAS : 1346527-98-7

ML240

Formule : C₂₃H₂₀N₆O

Degré de pureté : ≥98%

Masse moléculaire : 396.44

Ref: 54-BUP07038

ML240

CAS : 1346527-98-7

2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine

Formule : C₂₃H₂₀N₆O

Degré de pureté : 98+%

Masse moléculaire : 396.44

Ref: IN-DG630154

ML240

CAS : 1346527-98-7

ML240 is a selective, ATP-competitive p97 inhibitor.

Formule : C₂₃H₂₀N₆O

Degré de pureté : 99.73% - >99.99%

Couleur et forme : White Solid

Masse moléculaire : 396.44

Ref: TM-T3535

ML 240

CAS : 1346527-98-7

ML 240 is a potent inhibitor of cell proliferation and bone growth that has shown promising results in the treatment of cancer. It induces apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of specific proteins involved in the cell cycle. ML 240 has been tested on several cancer cell lines and has shown to be effective against various types of cancer. It works by blocking the activity of specific inhibitors that regulate protein expression, leading to cell death. ML 240 is a promising candidate for cancer therapy due to its ability to selectively target cancer cells while sparing normal cells.

Degré de pureté : Min. 95%

Masse moléculaire : 396.44

Ref: 3D-BM177450